Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 327 shares at $271.68 ($88K) on 2022-04-25, disclosed to the SEC on 2022-04-27.
Scheduled sale ($88k) by SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $267.37 | 60 | $16K | 18.2% |
| 2 | $268.46 | 80 | $21K | 24.4% |
| 3 | $269.51 | 83 | $22K | 25.4% |
| 4 | $271.68 | 104 | $28K | 32.1% |
| Total | $269.55 avg | 327 | $88K | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |